Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ANAB
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | John P. Schmid Director | ANAB AnaptysBio, Inc. | Sale | 522 | $57.40 | $30.0K Sale | Form 4 ↗ |
| Mar 30, 2026 | John P. Schmid Director | ANAB AnaptysBio, Inc. | Sale | 7,527 | $56.70 | $426.8K Sale | Form 4 ↗ |
| Mar 30, 2026 | John P. Schmid Director | ANAB AnaptysBio, Inc. | Sale | 12,596 | $55.71 | $701.7K Sale | Form 4 ↗ |
| Mar 27, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 100 | $65.99 | $6,599 Sale | Form 4 ↗ |
| Mar 27, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 3,038 | $65.20 | $198.1K Sale | Form 4 ↗ |
| Mar 27, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 3,155 | $64.19 | $202.5K Sale | Form 4 ↗ |
| Mar 27, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 2,592 | $63.35 | $164.2K Sale | Form 4 ↗ |
| Mar 27, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 1,012 | $62.15 | $62.9K Sale | Form 4 ↗ |
| Mar 27, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 550 | $60.63 | $33.3K Sale | Form 4 ↗ |
| Mar 27, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 490 | $59.62 | $29.2K Sale | Form 4 ↗ |
| Mar 27, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 3,662 | $58.62 | $214.7K Sale | Form 4 ↗ |
| Mar 27, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 2,570 | $57.91 | $148.8K Sale | Form 4 ↗ |
| Mar 27, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 510 | $56.61 | $28.9K Sale | Form 4 ↗ |
| Feb 11, 2026 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 10,000 | $54.00 | $540.0K Sale | Form 4 ↗ |
| Jan 15, 2026 | Magda Marquet Director | ANAB AnaptysBio, Inc. | Sale | 1,710 | $48.85 | $83.5K Sale | Form 4 ↗ |
| Jan 15, 2026 | Magda Marquet Director | ANAB AnaptysBio, Inc. | Sale | 9,290 | $48.12 | $447.0K Sale | Form 4 ↗ |
| Jan 8, 2026 | Paul F. Lizzul Chief Medical Officer | ANAB AnaptysBio, Inc. | Sale | 3,650 | $44.71 | $163.2K Sale | Form 4 ↗ |
| Jan 8, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 14,281 | $44.71 | $638.5K Sale | Form 4 ↗ |
| Jan 8, 2026 | Dennis Mulroy CHIEF FINANCIAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 2,515 | $44.71 | $112.4K Sale | Form 4 ↗ |
| Jan 8, 2026 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 2,210 | $44.71 | $98.8K Sale | Form 4 ↗ |
| Jan 7, 2026 | Paul F. Lizzul Chief Medical Officer | ANAB AnaptysBio, Inc. | Sale | 2,235 | $45.11 | $100.8K Sale | Form 4 ↗ |
| Jan 7, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 9,202 | $45.11 | $415.1K Sale | Form 4 ↗ |
| Jan 7, 2026 | Dennis Mulroy CHIEF FINANCIAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 1,908 | $45.11 | $86.1K Sale | Form 4 ↗ |
| Jan 7, 2026 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 500 | $47.23 | $23.6K Sale | Form 4 ↗ |
| Jan 7, 2026 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 1,841 | $46.13 | $84.9K Sale | Form 4 ↗ |
| Jan 7, 2026 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 5,281 | $45.38 | $239.7K Sale | Form 4 ↗ |
| Jan 7, 2026 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 2,017 | $45.11 | $91.0K Sale | Form 4 ↗ |
| Jan 5, 2026 | Paul F. Lizzul Chief Medical Officer | ANAB AnaptysBio, Inc. | Sale | 4,219 | $43.26 | $182.5K Sale | Form 4 ↗ |
| Jan 5, 2026 | Daniel Faga President, CEO, Director | ANAB AnaptysBio, Inc. | Sale | 15,309 | $43.26 | $662.3K Sale | Form 4 ↗ |
| Jan 5, 2026 | Dennis Mulroy CHIEF FINANCIAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 3,363 | $43.26 | $145.5K Sale | Form 4 ↗ |
| Jan 5, 2026 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 2,983 | $43.26 | $129.0K Sale | Form 4 ↗ |
| Dec 23, 2025 | J. Anthony Ware Director | ANAB AnaptysBio, Inc. | Sale | 3,900 | $49.58 | $193.4K Sale | Form 4 ↗ |
| Dec 22, 2025 | Paul F. Lizzul Chief Medical Officer | ANAB AnaptysBio, Inc. | Sale | 1,500 | $50.00 | $75.0K Sale | Form 4 ↗ |
| Dec 22, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 10,000 | $50.00 | $500.0K Sale | Form 4 ↗ |
| Dec 22, 2025 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 10,000 | $51.00 | $510.0K Sale | Form 4 ↗ |
| Dec 18, 2025 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 141 | $46.99 | $6,626 Sale | Form 4 ↗ |
| Dec 17, 2025 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 10,000 | $46.00 | $460.0K Sale | Form 4 ↗ |
| Dec 16, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 6,360 | $45.21 | $287.5K Sale | Form 4 ↗ |
| Dec 16, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 9,365 | $44.62 | $417.9K Sale | Form 4 ↗ |
| Dec 16, 2025 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 4,195 | $45.24 | $189.8K Sale | Form 4 ↗ |
| Dec 16, 2025 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 8,305 | $44.68 | $371.1K Sale | Form 4 ↗ |
| Sep 30, 2025 | Eric J. Loumeau CHIEF LEGAL OFFICER | ANAB AnaptysBio, Inc. | Sale | 8,240 | $29.00 | $239.0K Sale | Form 4 ↗ |
| Aug 8, 2025 | Hollings Renton Director | ANAB AnaptysBio, Inc. | Sale | 7,121 | $19.70 | $140.3K Sale | Form 4 ↗ |
| Aug 8, 2025 | Hollings Renton Director | ANAB AnaptysBio, Inc. | Sale | 3,110 | $19.44 | $60.5K Sale | Form 4 ↗ |
| Jul 2, 2025 | Hollings Renton Director | ANAB AnaptysBio, Inc. | Sale | 13,675 | $23.82 | $325.7K Sale | Form 4 ↗ |
| Jul 2, 2025 | Hollings Renton Director | ANAB AnaptysBio, Inc. | Sale | 7,250 | $23.09 | $167.4K Sale | Form 4 ↗ |
| Jun 18, 2025 | Dennis M. Fenton Director | ANAB AnaptysBio, Inc. | Sale | 3,015 | $23.97 | $72.3K Sale | Form 4 ↗ |
| Jun 18, 2025 | Hollings Renton Director | ANAB AnaptysBio, Inc. | Sale | 3,015 | $23.97 | $72.3K Sale | Form 4 ↗ |
| Jan 2, 2025 | EcoR1 Capital, LLC Director, 10% owner | ANAB AnaptysBio, Inc. | Buy | 6,646 | $12.95 | $86.1K Buy | Form 4 ↗ |
| Dec 31, 2024 | EcoR1 Capital, LLC Director, 10% owner | ANAB AnaptysBio, Inc. | Buy | 13,268 | $12.93 | $171.6K Buy | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:15 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances